OBSTETRICS: FETAL DIAGNOSIS AND THERAPYNoninvasive Prenatal Detection of Hemoglobin Bart Hydrops Fetalis Via Maternal Plasma Dispensed With Parental Haplotyping Using the Semiconductor Sequencing PlatformYang, Jiexia; Peng, Chun-fang; Qi, Yiming; Rao, Xing-qiang; Guo, Fangfang; Hou, Yaping; He, Wei; Wu, Jing; Chen, Yang-yi; Zhao, Xin; Wang, Yu-nan; Peng, Haishan; Wang, Dongmei; Du, Li; Luo, Ming-yong; Huang, Quan-fei; Liu, Hai-liang; Yin, AihuaAuthor Information Prenatal Diagnosis Centre, Maternal and Children Metabolic-Genetic Key Laboratory, Guangdong Women and Children Hospital (J.Y., Y.Q., F.G., Y.H., W.H., J.W., X.Z., Y.W., H.P., D.W., L.D., M.L., A.Y.); and CapitalBio Genomics Co, Ltd, Dongguan, and CapitalBio Technology Inc (C.P., X.R., Y.C., Q.H., H.L.), Beijing, China Obstetrical & Gynecological Survey: July 2020 - Volume 75 - Issue 7 - p 387-388 doi: 10.1097/01.ogx.0000688036.16759.76 Buy Metrics Abstract (Abstracted from Am J Obstet Gynecol 2020;222:185.e1–185.e17) Hemoglobin Bart's hydrops fetalis syndrome (Hb Bart's) is a common inherited genetic disease in the south of China and Southeast Asia. Couples who are both carriers of the Southeast Asian type of α-thalassemia gene deletion have a 25% risk of having a pregnancy affected with Hb Bart's as a result of autosomal recessive inheritance. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.